DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...

Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

Medtronic’s smart insulin pen doesn’t merely provide a streamlined method for managing diabetes—according to newly released data, it’s also effective at helping to regulate blood sugar levels and ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...

(RTTNews) - Healthcare technology firm Medtronic plc (MDT) announced Wednesday the U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed meal dose detection, paving ...

Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.

Please provide your email address to receive an email when new articles are posted on . People with diabetes who have difficulty meeting glycemic targets were better able to manage their glucose ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance for the Android version of the InPen app, making ...